Navigation Links
Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
Date:2/2/2009

le. We are pleased with the progress of our partnership with the U.S. Government, which has resulted in this important milestone, and we are hopeful that fulfillment of this initial order will result in a long-term relationship involving additional deliveries of ABthrax to the Stockpile."

ABthrax represents a new way to address the anthrax threat. While antibiotics can kill the anthrax bacteria, they are not effective against the deadly toxins that the bacteria produce. ABthrax targets anthrax toxins after they are released by the bacteria into the blood and tissues. In an inhalation anthrax attack, people may not know they are infected with anthrax until the toxins already are circulating in their blood, and it may be too late for antibiotics alone to be effective.

"We are delighted to have fulfilled this important milestone under our contract with the U.S. Government and we hope we are making a significant contribution to our nation's security," said James H. Davis, Ph.D., J.D., Executive Vice President and General Counsel, HGS, and leader of the Company's ABthrax program with the U.S. Government. "We are particularly pleased with the relationship we have had with BARDA in the development of ABthrax, and we look forward to continuing to work together."

About Research Findings to Date

In December 2007, HGS announced that the results of two animal studies demonstrated the life-saving potential of ABthrax (raxibacumab). The results showed that a single dose of raxibacumab, administered without concomitant antibiotics, improved survival rates by up to 64 percent when administered after animals were symptomatic for anthrax disease as a result of inhalation exposure to massively lethal doses of anthrax spores. These dramatic and statistically significant findings demonstrated a survival benefit in two animal species, which is the requirement for establishing the efficacy of new drugs used to
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation
2. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
3. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
4. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
5. 2008 Human Research Protection Award Recipients Announced
6. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
7. Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
8. SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial
9. GeoVaxs Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
10. Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions
11. Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sep. 03, 2015 ... announced the addition of the "Global Craniomaxillofacial ... offering. The global craniomaxillofacial devices market ... 2014-2019. This report covers the present and ... for 2015-2019. To calculate the market size, we ...
(Date:9/3/2015)... , Sept. 3, 2015 China,s ... Modoo Fetus Monitoring Patch, a wearable medical device that ... fetal movement data, providing safety guidance for pregnant women. ... The device, which measures 4 centimeters in ... weighs a little more than an Apple earphone cord. ...
(Date:9/3/2015)... 03, 2015 Research and ... the "Diabetes Care Devices Market In Brazil, Russia, ... Meters, Continuous Glucose Monitors, Testing Strips, Lancets, Insulin Pumps, ... report to their offering. The BRIC diabetes ... USD 1.7 Billion in 2015 and is poised to ...
Breaking Medicine Technology:Global Craniomaxillofacial (CMF) Devices Market 2015-2019 - Product Innovation and Cost Reduction a Key Market Trend 2Modoo to Debut at Kickstarter: First Device on the Market that Enables Continuous Monitoring of Fetal Heart Rate and Fetal Movement 2The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020 2The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020 3
... Dynatronics Corporation (Nasdaq: DYNT ) announced ... RB Milestone Portfolio, a group of companies selected by ... the market via a combination of traditional and innovative ... Network™, and non-deal roadshows, with a focus on the ...
... 16, 2011 McGraw-Hill Professional, a leading ... scientific and medical communities, and Simbionix™, the ... simulation technology, have partnered to bring surgical ... training resource AccessSurgery™ ( www.accesssurgery.com ) to ...
Cached Medicine Technology:Dynatronics Selected for Inclusion in RB Milestone Portfolio 2McGraw-Hill Professional and Simbionix™ Partner to Provide Enhanced Surgical Simulation and Education 2
(Date:9/3/2015)... ... September 03, 2015 , ... Real Time Pain Relief (RTPR), ... bull rider David Mason has signed an official endorsement deal with the company. Originally ... six and his first bull at 15. He is an Australian bull riding champion, ...
(Date:9/3/2015)... GA (PRWEB) , ... September 03, 2015 , ... ... cover the cost of graduated compression garments. However, graduated compression garments are an ... Wound care and lymphedema specialist, Robyn Bjork, was recently sponsored by SIGVARIS ...
(Date:9/3/2015)... ... September 03, 2015 , ... The first part of a two-part ... by IVC filter lawsuits filed against Bard.** These lawsuits, filed by persons ... IVC filter broke or failed, have recently been consolidated for pretrial proceedings as multidistrict ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... provider of comprehensive eating disorder treatment for adults and adolescents struggling with ... Calinoiu, MD has joined the medical treatment team. As a Staff Psychiatrist, ...
(Date:9/3/2015)... ... September 03, 2015 , ... Global Vision , the ... will be spotlighting its award-winning print and artwork inspection solutions, ScanProof and ... and 17 at the Olympia London, booth #F33 , Be the first to get ...
Breaking Medicine News(10 mins):Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 2Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 3Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3
... growing demand for user safety and cost effective solutions. Special purpose ... 2015. , ... San Jose, California (PRWEB) October 27, ... disposable needles, and related products has expanded considerably due to increasing ...
... regarded solely as disease agents -- now are being ... of these so-called oncolytic viruses stem from their potential ... discovered a way of controlling the viruses behind potential ... using microRNAs to restrict them to specific tissues. The ...
... NurseTesting Consulting Service is quickly becoming the nation’s leader ... early in 2008 and has already achieved six Joint Commission ... NurseTessting Consulting Service assures agencies understand and meet the healthcare ... ...
... cooling body, checking arteries lowers risk of further injury , , ... again is only the first step in saving a life ... An advisory, published in the Oct. 23 issue of ... after resuscitation or risk the losing the patient to the ...
... of visitors to Internet drug outlets nearly tripling in ... than ever. Based on its,assessment of more than 1,000 ... Boards of Pharmacy(R) (NABP(R)) finds,that 97% of these sites ... federal laws or established patient safety and pharmacy practice,standards. ...
... Comprehensive Cancer,Center announced that Judy and Larry Freeman ... USC/Norris Comprehensive Cancer Center, Keck School of,Medicine of ... Larry Freeman Cancer,Day Hospital, an outpatient facility currently ... Hospital. Larry Freeman is the founder of Freeman,Cosmetics ...
Cached Medicine News:Health News:Special Purpose Needles Market to Reach $3.7 Billion by 2015, According to New Report by Global Industry Analysts, Inc 2Health News:Special Purpose Needles Market to Reach $3.7 Billion by 2015, According to New Report by Global Industry Analysts, Inc 3Health News:MicroRNAs make for safer cancer treatments 2Health News:New Joint Commission Consulting Service by NurseTesting Grows Fast as Staffing Agencies Seek Joint Commission Certification 2Health News:New Joint Commission Consulting Service by NurseTesting Grows Fast as Staffing Agencies Seek Joint Commission Certification 3Health News:Speedy Care After Heart Attack Key to Survival 2Health News:NABP Findings Underscore Dangers of Purchasing Prescription Medicine Online and From Foreign Sources 2Health News:NABP Findings Underscore Dangers of Purchasing Prescription Medicine Online and From Foreign Sources 3Health News:USC Cancer Center Announces Contribution By Larry and Judy Freeman 2
1.0% Casein digest (NZ amine), 0.5% Sodium Chloride, 0.5% Yeast Extract, 1.0% bacto casamino acids, 0.2% Mag. Sulfate....
0.5% Yeast Extract, 2.0% Tryp, 10mM Sodium Chloride, 2.5mM Potassium Chloride....
SOC Kit for Bacterial Cells containing 10 x 5mls Sterile growth medium with instructions...
Innovative hemi device combining anatomic design with the advanced material pyrocarbon....
Medicine Products: